A manufacturer of automative components sees its shares bounce as it gets to grips with production issues. Elsewhere, a large veterinary services group is growing fast down under as the UK market remains under the scrutiny of a CMA review, while the stock market places little value on the operating businesses of a cash rich technology solutions group. Read on here for more on this and plenty of other positive news from AIM.
CVS: UK on pause (or paws!), Australia going strong
CVS Group (AIM:CVSG), the veterinary services group with a growing presence in Australia, announced an in-line trading update for its financial year to 30 June 2025.
Revenue from continuing operations grew 5.4% to £673.2m with like-for-like sales (excluding the impact of acquisitions) increasing by 0.2%. Growth was impacted by softer market conditions in the UK.
Access the all latest company comments on Investor's Champion.
Not yet registered? It's free to register. Register now.
Register on Investor's Champion
Access the all latest company comments on Investor's Champion.
Premium Content
Premium content provides more in-depth information on fascinating investment stories and research to help make your money go further.
Access Premium Content through individual credits (we only want you to read what you are interested in) or through an annual subscription, which works out as only 25p per day – a small price to guide you through the investing maze!
Subscription
Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
In depth coverage of many of the world’s great companies
Breaking news on potential upcoming disasters
Unique insights from our top research team
Credits
Get access to our premium content for as little as £3.20 per article.
